OTCPK:ARLZQ - Post by User
Post by
kuatoliveson Aug 15, 2016 8:25am
![](https://assets.stockhouse.com/kentico-cms/0338-00/images/Sprite.svg#id_Post_Views_Icon)
82 Views
Post# 25141428
Guggenheim/Chardan re-iterate
Guggenheim/Chardan re-iteratetheir buy ratings and $10-12/share expectation. (As far as that goes without FDA approval of Yosprala).
Down to 4 weeks (or less)......